Corrigendum to “Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score” [Eur. Urol. 83(5) (2024) 432–440]
Year: 2024
Type: erratum
Abstract: International audience
Source: European Urology
Authors: Matthew D. Galsky, Dean F. Bajorin, Johannes Alfred Witjes, Jürgen E. Gschwend, Yoshihiko Tomita, Federico Nasroulah, Jun Li, Sandra Collette, Begoña P. Valderrama, Marc-Oliver Grimm, Leonard Appleman, Gwenaelle Gravis, Andrea Necchi, Dingwei Ye, Frank Stenner, Megan Wind-Rotolo, Joshua Zhang, Keziban Ünsal-Kaçmaz
Institutions: Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, Radboud University Nijmegen, Technical University of Munich, Niigata University, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Belgium), Hospital Universitario Virgen del Rocío, Jena University Hospital, UPMC Hillman Cancer Center, Aix-Marseille Université, Institut Paoli-Calmettes, Fondazione IRCCS Istituto Nazionale dei Tumori, Fudan University Shanghai Cancer Center, University Hospital of Basel
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,250
OpenAlex ID: W4390534344